Evidence map›Paper›PMID 27500929›Full record

ArticlePloS one2016

In Vivo Cannulation Methods for Cardiomyocytes Isolation from Heart Disease Models.

Zhong Jian, Yi-Je Chen, Rafael Shimkunas, Yuwen Jian, Mark Jaradeh, Karen Chavez, Nipavan Chiamvimonvat, Jil C Tardiff, Leighton T Izu, Robert S Ross and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Guidelines for experimental models of myocardial ischemia and infarction.American journal of physiology. Heart and circulatory physiology · 2018
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zhong JianDepartment of Pharmacology, University of California Davis, Davis, California, United States of America.ORCID http://orcid.org/0000-0003-1072-5788
Yi-Je ChenDepartment of Pharmacology, University of California Davis, Davis, California, United States of America.
Rafael ShimkunasDepartment of Pharmacology, University of California Davis, Davis, California, United States of America.
Yuwen JianDepartment of Pharmacology, University of California Davis, Davis, California, United States of America.
Mark JaradehDepartment of Pharmacology, University of California Davis, Davis, California, United States of America.
Karen ChavezDepartment of Pharmacology, University of California Davis, Davis, California, United States of America.
Nipavan ChiamvimonvatDepartment of Internal Medicine, Division of Cardiology, University of California Davis, Davis, California, United States of America.
Jil C TardiffDepartment of Medicine and Cellular & Molecular Medicine, University of Arizona, Tucson, Arizona, United States of America.
Leighton T IzuDepartment of Pharmacology, University of California Davis, Davis, California, United States of America.
Robert S RossVeterans Administration Healthcare System, Cardiology Section, University of California San Diego, San Diego, California, United States of America.
Ye Chen-IzuDepartment of Pharmacology, University of California Davis, Davis, California, United States of America.
University of California, Davis · USUniversity of Arizona · USUniversity of California San Diego · US

Funding

Functional Interactions of Cardiac Ion ChannelsR01HL085844 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHIAMVIMONVAT, NIPAVAN · 2007 to 2025
$7.3M
Training Program In Basic & Translational Cardiovascular ScienceT32HL086350 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Martin Cadeiras, David A. Liem · 2008 to 2026
$7.1M
Translational Study of Cardiac DysfunctionR01HL085727 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHIAMVIMONVAT, NIPAVAN, SIRISH, PADMINI · 2008 to 2022
$5.7M
Integrins and Caveolin Proteins in Cardiac Hypertrophy and FailureR01HL115933 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSS, ROBERT SCOTT, ROTH, DAVID M · 2013 to 2016
$2.6M
Decoding the enigma of cardiac amplificationR01HL137228 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHIAMVIMONVAT, NIPAVAN · 2017 to 2020
$2.2M
Novel Cell-in-Gel System for Mechanotransduction Study at the Single Cell LevelR01HL123526 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN-IZU, YE · 2015 to 2018
$1.8M
Cardiac Myocyte Form and Function: Role of Talin and KindlinR01HL127806 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSS, ROBERT SCOTT · 2015 to 2018
$1.6M
Sarcomere Length Shortening and the Destabilization of the Ca2+ Control System inR01HL090880 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IZU, LEIGHTON T. · 2009 to 2012
$1.5M
Regulation of ion channels in the heartI01BX000576 · VA · VA NORTHERN CALIFORNIA HEALTH CARE SYS · PI CHIAMVIMONVAT, NIPAVAN · 2009 to 2019
–
Metabolomics study in patients post myocardial infarctionI01CX001490 · VA · VA NORTHERN CALIFORNIA HEALTH CARE SYS · PI CHIAMVIMONVAT, NIPAVAN · 2017 to 2021
–
BLRD VA I01 BX000576CSRD VA I01 CX001490NHLBI NIH HHS R01 HL085727NHLBI NIH HHS R01 HL085844NHLBI NIH HHS R01 HL090880NHLBI NIH HHS R01 HL115933NHLBI NIH HHS R01 HL123526NHLBI NIH HHS R01 HL127806NHLBI NIH HHS R01 HL137228NHLBI NIH HHS T32 HL086350
6 · The paper itself

Abstract

Isolation of high quality cardiomyocytes is critically important for achieving successful experiments in many cellular and molecular cardiology studies. Methods for isolating cardiomyocytes from the murine heart generally are time-sensitive and experience-dependent, and often fail to produce high quality cells. Major technical difficulties can be related to the surgical procedures needed to explant the heart and to cannulate the vessel to mount onto the Langendorff system before in vitro reperfusion can begin. During this period, transient hypoxia and ischemia may damage the heart, resulting in low yield and poor quality of cells, especially for heart disease models that have fragile cells. We have developed novel in vivo cannulation methods to minimize hypoxia and ischemia, and fine-tuned the entire protocol to produce high quality ventricular myocytes. The high cell quality has been confirmed using important structural and functional criteria such as morphology, t-tubule structure, action potential morphology, Ca2+ signaling, responsiveness to beta-adrenergic agonist, and ability to have robust contraction under mechanically loaded condition. Together these assessments show the preservation of the cardiac excitation-contraction machinery in cells isolated using this technique. The in vivo cannulation method enables consistent isolation of high-quality cardiomyocytes, even from heart disease models that were notoriously difficult for cell isolation using traditional methods.

Indexed as

Action PotentialsAdrenergic beta-AgonistsAnimalsAortaCalcium SignalingCardiac CatheterizationCarotid ArteriesCell SeparationIsoproterenolMaleMice, Inbred C57BLMice, TransgenicMyocardial ContractionMyocytes, CardiacAdrenergic beta-AgonistsIsoproterenol

Identifiers

PMID27500929
PMCPMC4976940
OpenAlexW2512635991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.